Copyright Reports & Markets. All rights reserved.

Global Basal Insulin (Long-Acting Insulin) Sales Market Report 2021

Request for Sample of this report
Buy now

1 Basal Insulin (Long-Acting Insulin) Market Overview

  • 1.1 Basal Insulin (Long-Acting Insulin) Product Scope
  • 1.2 Basal Insulin (Long-Acting Insulin) Segment by Type
    • 1.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Lantus
    • 1.2.3 Levemir
    • 1.2.4 Tresiba
    • 1.2.5 Toujeo
    • 1.2.6 Basaglar
    • 1.2.7 Biosimilar Glargines
  • 1.3 Basal Insulin (Long-Acting Insulin) Segment by Application
    • 1.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Type 1 Diabetes
    • 1.3.3 Type 2 Diabetes
  • 1.4 Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Basal Insulin (Long-Acting Insulin) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Basal Insulin (Long-Acting Insulin) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Basal Insulin (Long-Acting Insulin) Price Trends (2016-2027)

2 Basal Insulin (Long-Acting Insulin) Estimates and Forecasts by Region

  • 2.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Basal Insulin (Long-Acting Insulin) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)
    • 2.4.3 China Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)
    • 2.4.6 India Basal Insulin (Long-Acting Insulin) Estimates and Projections (2016-2027)

3 Global Basal Insulin (Long-Acting Insulin) Competition Landscape by Players

  • 3.1 Global Top Basal Insulin (Long-Acting Insulin) Players by Sales (2016-2021)
  • 3.2 Global Top Basal Insulin (Long-Acting Insulin) Players by Revenue (2016-2021)
  • 3.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2020)
  • 3.4 Global Basal Insulin (Long-Acting Insulin) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Basal Insulin (Long-Acting Insulin) Market Size by Type

  • 4.1 Global Basal Insulin (Long-Acting Insulin) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2016-2021)
  • 4.2 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Basal Insulin (Long-Acting Insulin) Price Forecast by Type (2022-2027)

5 Global Basal Insulin (Long-Acting Insulin) Market Size by Application

  • 5.1 Global Basal Insulin (Long-Acting Insulin) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2016-2021)
  • 5.2 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Basal Insulin (Long-Acting Insulin) Price Forecast by Application (2022-2027)

6 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 6.1 North America Basal Insulin (Long-Acting Insulin) Sales by Company
    • 6.1.1 North America Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 6.1.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 6.2 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 6.2.1 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 6.3.1 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2022-2027)

7 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 7.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Company
    • 7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 7.2 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 7.2.1 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 8.1 China Basal Insulin (Long-Acting Insulin) Sales by Company
    • 8.1.1 China Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 8.1.2 China Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 8.2 China Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 8.2.1 China Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 8.3 China Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 8.3.1 China 245 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 9.1 Japan Basal Insulin (Long-Acting Insulin) Sales by Company
    • 9.1.1 Japan Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 9.1.2 Japan Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 9.2 Japan Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 9.2.1 Japan Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 10.1 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales by Company
    • 10.1.1 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Basal Insulin (Long-Acting Insulin) Market Facts & Figures

  • 11.1 India Basal Insulin (Long-Acting Insulin) Sales by Company
    • 11.1.1 India Basal Insulin (Long-Acting Insulin) Sales by Company (2016-2021)
    • 11.1.2 India Basal Insulin (Long-Acting Insulin) Revenue by Company (2016-2021)
  • 11.2 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type
    • 11.2.1 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2022-2027)
  • 11.3 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application
    • 11.3.1 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Basal Insulin (Long-Acting Insulin) Business

  • 12.1 Novo Nordisk
    • 12.1.1 Novo Nordisk Corporation Information
    • 12.1.2 Novo Nordisk Business Overview
    • 12.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.1.5 Novo Nordisk Recent Development
  • 12.2 Sanofi Aventis
    • 12.2.1 Sanofi Aventis Corporation Information
    • 12.2.2 Sanofi Aventis Business Overview
    • 12.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.2.5 Sanofi Aventis Recent Development
  • 12.3 Eli Lilly
    • 12.3.1 Eli Lilly Corporation Information
    • 12.3.2 Eli Lilly Business Overview
    • 12.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.3.5 Eli Lilly Recent Development
  • 12.4 Biocon
    • 12.4.1 Biocon Corporation Information
    • 12.4.2 Biocon Business Overview
    • 12.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Biocon Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.4.5 Biocon Recent Development
  • 12.5 Julphar
    • 12.5.1 Julphar Corporation Information
    • 12.5.2 Julphar Business Overview
    • 12.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Julphar Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.5.5 Julphar Recent Development
  • 12.6 Exir
    • 12.6.1 Exir Corporation Information
    • 12.6.2 Exir Business Overview
    • 12.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Exir Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.6.5 Exir Recent Development
  • 12.7 Sedico
    • 12.7.1 Sedico Corporation Information
    • 12.7.2 Sedico Business Overview
    • 12.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Sedico Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.7.5 Sedico Recent Development
  • 12.8 Wockhardt
    • 12.8.1 Wockhardt Corporation Information
    • 12.8.2 Wockhardt Business Overview
    • 12.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Products Offered
    • 12.8.5 Wockhardt Recent Development

13 Basal Insulin (Long-Acting Insulin) Manufacturing Cost Analysis

  • 13.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
  • 13.4 Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Basal Insulin (Long-Acting Insulin) Distributors List
  • 14.3 Basal Insulin (Long-Acting Insulin) Customers

15 Market Dynamics

  • 15.1 Basal Insulin (Long-Acting Insulin) Market Trends
  • 15.2 Basal Insulin (Long-Acting Insulin) Drivers
  • 15.3 Basal Insulin (Long-Acting Insulin) Market Challenges
  • 15.4 Basal Insulin (Long-Acting Insulin) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Basal Insulin (Long-Acting Insulin) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Basal Insulin (Long-Acting Insulin) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Lantus
    Levemir
    Tresiba
    Toujeo
    Basaglar
    Biosimilar Glargines

    Segment by Application
    Type 1 Diabetes
    Type 2 Diabetes

    The Basal Insulin (Long-Acting Insulin) market is analysed and market size information is provided by regions (countries). Segment by Application, the Basal Insulin (Long-Acting Insulin) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Novo Nordisk
    Sanofi Aventis
    Eli Lilly
    Biocon
    Julphar
    Exir
    Sedico
    Wockhardt

    Buy now